Barry Robins

Barry Robins has extensive work experience in the pharmaceutical and healthcare industry. Barry started their career as a Chemist at G.D. Searle/Monsanto in 1983 and worked there until 1991. From 1991 to 2002, they worked at Sigma Diagnostics as an R&D Manager and later as a QA/RA Manager. Barry then joined Sigma Aldrich as a QA Manager in 2002. In 2004, they moved to Millennium Pharmaceuticals and worked as an Associate Director of Investigational QA until 2012. From 2012 to 2016, they served as an Associate Director of Commercial Quality at Millennium Pharmaceuticals. Barry then joined Takeda Pharmaceuticals International Co. as an Associate Director of Technical Operation, GMS from 2016 to 2018. From 2019 to 2022, they worked at Magenta Therapeutics as an Associate Director of Quality and later as a Director of Quality. In 2022, they joined RVAC Medicines as a Director of Product Quality Lead and later moved to ImmunoGen, Inc. in 2023, where they currently hold the position of Director of Product Quality.

Barry Robins obtained a Bachelor of Arts degree in Chemistry from The Johns Hopkins University from 1975-1979. Barry then went on to pursue a PhD in Chemistry from Rice University, which they completed from 1979-1983.